CUSIP 50180M108COM SHSLBRXQ4 2025
12 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Deep Track Capital, LP | 3.35M | $74.63M |
| 2 | Blackrock, Inc. | 2.24M | $49.84M |
| 3 | Ra Capital Management, L.P. | 2.21M | $49.16M |
| 4 | Tcg Crossover Management, LLC | 1.75M | $38.84M |
| 5 | Jpmorgan Chase & Co | 1.61M | $35.87M |
| 6 | Commodore Capital LP | 1.50M | $33.39M |
| 7 | Trails Edge Capital Partners, LP | 1.40M | $31.07M |
| 8 | Logos Global Management LP | 1.20M | $26.71M |
| 9 |
| 4 | Jan 21, 2026 | Blackrock, Inc. | 13G | 5.1% | 1.28M | SEC |
| 5 | Jan 21, 2026 | Jpmorgan Chase &Amp; Co. | 13G | 6.3% | 1.61M | SEC |
| 6 | Dec 31, 2025 | Trails Edge Capital Partners, LP | 13G | 5.0% | 1.27M | SEC |
| 7 | Oct 17, 2025 | Blackrock Portfolio Management LLC | 13G | 5.9% | 975.0K | SEC |
| 8 | Sep 25, 2025 | Pontifax Management 4 G.P. (2015) Ltd. | 13D | 6.3% | — | SEC |
| 9 | Sep 19, 2025 | Ra Capital Management, L.P. | 13G | 7.5% | 1.68M | SEC |
| 10 | Sep 19, 2025 | Deep Track Biotechnology Master Fund, Ltd. | 13D | 14.9% | — | SEC |
See the full Schedule 13D/13G history for Lb Pharmaceuticals Inc.
Unlock full history| Vanguard Group Inc |
| 1.11M |
| $24.77M |
| 10 | Spruce Street Capital LP | 1.01M | $22.38M |